Location permission needed for a better experience.
How can we help you?
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2000 Trakya Üniversitesi Tıp Fakültesi Nükleer Tıp
  • 1992 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi
EXPERIENCE
  • 2024 Acıbadem Sağlık Grubu
  • 2017 - 2024 Sağlık Bilimleri Üniversitesi, Hamidiye Tıp Fakültesi / Prof.Dr. Öğretim Üyesi
  • 2011 - 2024 Eğitim Sorumlusu, İstanbul Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği
  • 2011 - 2024 İdari Sorumlu, İstanbul Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği
  • 2022 - 2023 İstanbul Eğitim ve Araştırma Hastanesi / Prof.Dr. Eğitim Sorumlusu
  • 2021 - 2023 Yönetim Kurulu Başkanı, Türkiye Nükleer Tıp Derneği
  • 2017 - 2023 İstanbul Eğitim ve Araştırma Hastanesi / Prof.Dr. Eğitim ve İdari Sorumlu
  • 2014 - 2021 Yönetim Kurulu Genel Sekreteri, Türkiye Nükleer Tıp Derneği
  • 2017 - 2020 Sağlık Bilimleri Üniversitesi, Hamidiye Tıp Fakültesi / Prof.Dr. Anabilim Dalı Başkanı
  • 2017 - 2020 Anabilim Dalı Başkanı; S.B.Ü. Hamidiye Tıp Fakültesi, Nükleer Tıp ABD
  • 2014 - 2019 Baş Editör, İstanbul Medical Journal- İstanbul Tıp Dergisi
  • 2015 - 2018 Yardımcı Editör, Nükleer Tıp Seminerleri
  • 2015 - 2017 Anabilim Dalı Başkanı; Sakarya Üniversitesi, Tıp Fakültesi, Nükleer Tıp ABD
  • 2015 - 2017 Sakarya Üniversitesi, Tıp Fakültesi / Prof.Dr. Anabilim Dalı Başkanı
  • 2011 - 2015 İstanbul Eğitim ve Araştırma Hastanesi / Doç.Dr. Eğitim ve İdari Sorumlusu
  • 2012 - 2014 Yardımcı Editör, İstanbul Medical Journal- İstanbul Tıp Dergisi
  • 2007 - 2011 Klinik Şefi, İstanbul Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği
  • 2007 - 2011 İstanbul Eğitim ve Araştırma Hastanesi / Doç.Dr. Kurucu Klinik Şefi
  • 2006 - 2007 Trakya Üniversitesi Tıp Fakültesi / Doç.Dr.
  • 2005 - 2006 merika Birleşik Devletleri, Pennsylvania Üniversitesi Hastanesi, Radyoloji-Nükleer Tıp Departmanı Research Fellow
  • 2001 - 2006 Trakya Üniversitesi Tıp Fakültesi / Yard.Doç.Dr.
  • 2000 - 2001 Trakya Üniversitesi Tıp Fakültesi / Uz.Dr.
  • 1995 - 2000 Trakya Üniversitesi Tıp Fakültesi / Dr. Arş.Gör.
  • 1993 - 1995 Bolu Devlet Hastanesi / Dr.
  • 1992 - 1993 Siirt Eruh Devlet Hastanesi / Dr.
MEMBERSHIPS
  • Türkiye Nükleer Tıp Derneği
  • Avrupa Nükleer Tıp Derneği (European Association of Nuclear Medicine)
PUBLICATIONS
  • Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging: Complementary Role in PSMA-Negative Cases. Clin Nucl Med. 2024 Mar 1;49(3):e105-e110. doi: 10.1097/RLU.0000000000005064. Epub 2024 Jan 25.PMID: 38271254 Ergül N, Çermik TF, Alçın G, Arslan E, Erol Fenercioğlu Ö, Beyhan E, Şahin R, Baloğlu MC, Baykal Koca S, Türkay R, Yücetaş U.
  • 68 Ga-PSMA PET/CT Found Lower Respiratory Tract Inflammation Due to Inhaler Use. Clin Nucl Med. 2024 Feb 1;49(2):e75-e76. doi: 10.1097/RLU.0000000000005015. Epub 2023 Dec 22. PMID: 38170919. Beyhan E, Aksoy T, Alçin G, Arslan E, Çermik TF
  • Comparison of 18 F-FDG PET/CT and 68 Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer. Clin Nucl Med. 2024 Feb 1;49(2):e68-e69. doi: 10.1097/RLU.0000000000004970. Epub 2023 Dec 22. PMID: 38170920. Öztürk AE, Şahin R, Ergül N, Çermik TF, Arslan E.
  • Investigation of Clinical Histopathologic Features and Metabolic Parameters of 18F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component. Mol Imaging Radionucl Ther. 2023 Oct 20;32(3):221-225. doi: 10.4274/mirt.galenos.2023.06078. PMID: 37870289. Akgün E, Alçın G, Kelten Talu EC, Çermik TF, Söylemez Akkurt T, Şen E, Arslan E.
  • The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions. Nucl Med Commun. 2023 Oct 1;44(10):896-899. doi: 10.1097/MNM.0000000000001734. Epub 2023 Jul 14. PMID: 37450605. Erol Fenercioğlu Ö, Beyhan E, Şahin R, Baloğlu MC, Arslan E, Çermik TF, Ergül N.
  • Formulation and In-vivo Characterization of 177Lu-tin-colloid as a Radiosynovectomy Agent. Curr Radiopharm. 2023 Nov 3. doi: 10.2174/0118744710252994231024064842. Epub ahead of print. PMID: 37937551. Mercanoglu G, Alcın G, Ozturkmen Y, Cermik T.
  • A multi-institutional assessment of eye lens dose in nuclear medicine clinics. Nucl Med Commun. 2023 Sep 1;44(9):772-776. doi: 10.1097/MNM.0000000000001727. Epub 2023 Jul 18. PMID: 37464817. Abuqbeitah M, Demir M, Işikci NI, Kozanlilar B, Kovan B, Yeyin N, Çermik TF, Şanli Y, Sönmezoğlu K.
  • 68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study. Clin Nucl Med. 2023 Sep 1;48(9):e420-e430. doi: 10.1097/ RLU.0000000000004751. Epub 2023 Jun 23. PMID: 37351868. Alçın G, Arslan E, Aksoy T, Cin M, Erol Fenercioğlu Ö, Beyhan E, Ergül N, Çermik TF.
  • Pneumonia with Intense 68Ga-FAPI Uptake Mimicking Metastasis on 68Ga-FAPI PET/CT in a Patient with Rectal Cancer. Mol Imaging Radionucl Ther. 2023 Oct 20;32(3):237-238. doi: 10.4274/mirt.galenos. 2023.07830. PMID: 37870301. Erol Fenercioğlu Ö, Beyhan E, Samancı NŞ, Çermik TF, Ergül N.
  • 68Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor. Clin Nucl Med. 2023 Oct 1;48(10):e480-e482. doi: 10.1097/RLU.0000000000004782. Epub 2023 Aug 3. PMID: 37565817. Alçın G, Arslan E, Baykara Ulusan M, Aksoy T, Ergül N, Çermik TF.
  • Prognostic Role of Interleukin-23 in Prostate Adenocarcinoma: Comparison with Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography Findings. İstanbul Med J 2021;22:320-325. Gündoğan C, Ergül N, Serin H, Beyhan E, Yılmaz B, Çermik TF.
  • Giant Polyostotic Fibrous Dysplasia: F-18-flourodeoxyglucose Positron Emission Tomography/Computerized Tomography and Radiologic Findings İstanbul Med J 2020;21: 145-7. Baykara Ulusan M, Çermik TF.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 444 55 44 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP